Related references
Note: Only part of the references are listed.T Cell Activation
Jennifer E. Smith-Garvin et al.
ANNUAL REVIEW OF IMMUNOLOGY (2009)
Tumor antigen-specific CD8 T cells infiltrating the tumor express high levels of PD-1 and are functionally impaired
Mojgan Ahmadzadeh et al.
BLOOD (2009)
In vitro induction of T cells that are resistant to A(2) adenosine receptor-mediated immunosuppression
Akio Ohta et al.
BRITISH JOURNAL OF PHARMACOLOGY (2009)
Adoptive cell therapy for the treatment of patients with metastatic melanoma
Steven A. Rosenberg et al.
CURRENT OPINION IN IMMUNOLOGY (2009)
Cooperation of adenosine and prostaglandin E2 (PGE2) in amplification of cAMP-PKA signaling and immunosuppression
Yunyun Su et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2008)
Internalization and desensitization of adenosine receptors
Elisabeth C. Klaasse et al.
PURINERGIC SIGNALLING (2008)
Aspects of the general biology of adenosine A2A signaling
Bertil B. Fredholm et al.
PROGRESS IN NEUROBIOLOGY (2007)
Inhibition of cytokine production and cytotoxic activity of human antimelanoma specific CD8+ and CD4+ T lymphocytes by adenosine-protein kinase a type I signaling
Tatiana Raskovalova et al.
CANCER RESEARCH (2007)
Immune resistance orchestrated by the tumor microenvironment
Thomas F. Gajewski et al.
IMMUNOLOGICAL REVIEWS (2006)
A2A adenosine receptor protects tumors from antitumor T cells
Akio Ohta et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Modulation by IL-2 of CD70 and CD27 expression on CD8+ T cells:: Importance for the therapeutic effectiveness of cell transfer immunotherapy
Jianping Huang et al.
JOURNAL OF IMMUNOLOGY (2006)
Cyclic nucleotide phosphodiesterases: Molecular regulation to clinical use
Andrew T. Bender et al.
PHARMACOLOGICAL REVIEWS (2006)
Negative regulation of T-cell receptor activation by the cAMP-PKA-Csk signalling pathway in T-cell lipid rafts
Kjetil Tasken et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2006)
Tumor progression can occur despite the induction of very high levels of self/tumor antigen-specific CD8+ T cells in patients with melanoma
SA Rosenberg et al.
JOURNAL OF IMMUNOLOGY (2005)
GS protein-coupled adenosine receptor signaling and lytic function of activated NK cells
T Raskovalova et al.
JOURNAL OF IMMUNOLOGY (2005)
Cyclooxygenase inhibitors modulate NK activities that control metastatic disease
N Kundu et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2005)
The 'danger' sensors that STOP the immune response: the A2 adenosine receptors?
MV Sitkovsky et al.
TRENDS IN IMMUNOLOGY (2005)
Transition of late-stage effector T cells to CD27(+) CD28(+) tumor-reactive effector memory T cells in humans after adoptive cell transfer therapy
DJ Powell et al.
BLOOD (2005)
Cancer immunotherapy: moving beyond current vaccines
SA Rosenberg et al.
NATURE MEDICINE (2004)
Knockdown of C-terminal Src kinase by siRNA-mediated RNA interference augments T cell receptor signaling in mature T cells
T Vang et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2004)
Pharmacology and signaling of prostaglandin receptors: Multiple roles in inflammation and immune modulation
AN Hata et al.
PHARMACOLOGY & THERAPEUTICS (2004)
Physiological control of immune response and inflammatory tissue damage by hypoxia-inducible factors and adenosine A(2A) receptors
MV Sitkovsky et al.
ANNUAL REVIEW OF IMMUNOLOGY (2004)
Adenosine: an endogenous regulator of innate immunity
G Hasko et al.
TRENDS IN IMMUNOLOGY (2004)
Targeting cyclooxygenase-2 in human neoplasia: Rationale and promise
AJ Dannenberg et al.
CANCER CELL (2003)
Combined spatial and enzymatic regulation of Csk by cAMP and protein kinase A inhibits T cell receptor signaling
T Vang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
PI3K in lymphocyte development, differentiation and activation
K Okkenhaug et al.
NATURE REVIEWS IMMUNOLOGY (2003)
Cancer regression and autoimmunity in patients after clonal repopulation with antitumor lymphocytes
ME Dudley et al.
SCIENCE (2002)
Prostaglandins as modulators of immunity
SG Harris et al.
TRENDS IN IMMUNOLOGY (2002)
Immune-mediated eradication of tumors through the blockade of transforming growth factor-β signaling in T cells
L Gorelik et al.
NATURE MEDICINE (2001)
Release from tonic inhibition of T cell activation through transient displacement of C-terminal Src kinase (Csk) from lipid rafts
KM Torgersen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Activation of the COOH-terminal Src kinase (Csk) by cAMP-dependent protein kinase inhibits signaling through the T cell receptor
T Vang et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2001)
Gene dose effect reveals no Gs-coupled A2A adenosine receptor reserve in murine T-lymphocytes:: studies of cells from A2A-receptor-gene-deficient mice
JM Armstrong et al.
BIOCHEMICAL JOURNAL (2001)
Share Paper
